I think MedReleaf was hit overly hard in the Canadian LP correction and expect it to recover about 1/2 its losses from the all-time high of C$31.25 to the low of C14.75 on 2/5. The company's financial report for FY18-Q3 showed an acceleration in sales to an all-time high after digesting changes in the Veterans Affairs program over the past several quarters....